- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Evaluate the Plasma Iron Levels on Iraqi Type 2 Diabetic Nephropathy | ||
| Journal of University of Anbar for Pure Science | ||
| Article 4, Volume 11, Issue 1, 2017, Pages 9-13 | ||
| Document Type: Research Paper | ||
| DOI: 10.37652/juaps.2017.141526 | ||
| Authors | ||
| Shakir Faris Tuleab1; Sarah Mohammed Abd-Allah1; Maher Ahmed Abed2 | ||
| 1College of Education for Pure Sciences, University of Anbar | ||
| 2College of Agriculture, University of Anbar. | ||
| Abstract | ||
| Diabetes is linked with a change of homeostasis for the plasma iron in human, that have the ability to produce reactive oxygen species (ROS) induced by this disease and its microangiopathy complication especially diabetic nephropathy (DN). In addition, iron indicators are associated with obesity and insulin sensitivity as contribute to the development and improvement of oxidative damage. The objective of the study was to measure and evaluate the level of iron in the plasma in diabetic patients with and without DN, and in normal individuals, The current study was conducted on sixty T2D patients diagnosed beforehand, these patients were categorized into two equal groups according to their albumin to Creatinine ratio (ACR), including patient with nephropathy (UAC=30-300 mg/g Creatinine), (I) and patients without nephropathy (UAC<30mg/g Creatinine), (II). Twenty four healthy persons were chosen as a control group. Each group included the same numbers of male and female. The age of patients ranged from (36-65) year . The results showed that the plasma level of iron showed a high significant increasing in patients without DN group (177.10±76.36 μg/dl) compared to patients with DN and healthy control groups (126.77±61.16 vs 116.79±26.16 μg/dl, respectively). | ||
| Keywords | ||
| Diabetic Nephropathy; DM and plasma Iron | ||
| References | ||
|
[1]- American Diabetes Association. (2015). "Standards of medical care in diabetes". Diabetes Care, 38(suppl 1): S1-S93.
[2]- Najafian B, Alpers CE, Fogo AB. (2011). "Pathology of human diabetic nephropathy". Contrib Nephrol, 170: 36-47.
[3]- Tervaert TW, Mooyaart AL, Amann K, et al,. (2010). " Pathologic classification of diabetic nephropathy". J Am Soc Nephrol, 21(4): 556-563.
[4]- Andrews NC. (1999)." Medical progress: Disorders of iron metabolism". N Engl J Med. 341(26): 1986-1995.
[5]- Dongiovanni, P. Fracanzani, A. Fargion, S. Valenti, L. (2011). "Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target". J Hepatol. 55(4): 920–932.
[6]- Sampaio AFS., Silva M, Dornas WC, et al. (2014). "Iron toxicity mediated by oxidative stress enhances tissue damage in an animal model of diabetes". Bio Metals, 27(2): 349–361.
[7]- Zein S, Rachidi S, and Hininger-Favier I. (2014). "Is oxidative stress induced by iron status associated with gestational diabetes mellitus?". Journal of Trace Elements in Medicine and Biology, 28(1): 65–69.
[8]- Guo L, Jiang F, Tang YT, et al,. (2014). "The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease," Diabetes Technology &Therapeutics, 16(4): 224–234.
[9]- Martines AMF, Masereeuw R, Tjalsma H, et al. (2013). "Iron metabolism in the pathogenesis of iron-induced kidney injury".Nature Reviews Nephrology. 9(7): 385–398.
[10]- Giacco F and Brownlee M. (2010). "Oxidative stress and diabetic complications". Circ Res,. 107(9): 1058-1070.
[11]- Kapoor S and Sharma AK. (2015). " Study of Serum Parameters of iron Metabolism in Type 2 Diabetes Mellitus Patients".J,Chem.Pharm.Res., 7(3): 1839-1844.
[12]- Giacco F and Brownlee M,. (2010). "Oxidative stress and diabetic complications". Circ Res,. 107(9): 1058-1070.
[13]- Kapoor S and Sharma AK,. (2015). " Study of Serum Parameters of iron Metabolism in Type 2 Diabetes Mellitus Patients". J,Chem.Pharm.Res., 7(3): 1839-1844.
[14]- Fernandez-Real JM, Lopez-Bermejo A and Ricart W,. (2002). "Cross- talk between iron metabolism and diabetes". Diabetes,. 51(8): 2348–2354.
[15]- Duffy SJ, Biegelsen ES, Holbrook M, et al,. (2001) "Iron chelation improves endothelial function in patients with coronary artery disease". Circulation,. 103(23): 2799–2704. | ||
|
Statistics Article View: 674 PDF Download: 174 |
||